©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 112514
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112514
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112514
Figure 2 Linc01010 exercised its regulatory goal by targeting binding to mitogen-activated protein kinase kinase 6 protein through specific exon domains.
A and B: Quantitative polymerase chain reaction and luciferase assay for MCF-7 cells were conducted to reveal the functional localization of Linc01010 exon components in breast cancer cells; C and D: Electrophoretic mobility shift assays and RNA-Protein Pull-Down Assay were utilized to investigate evidence of Linc01010 binding to target protein in breast cancer cells. The mean ± SD for three independent experiments and analyzed using Statistical Package for Social Science software, 20 μM Chidamide vs Basal at aP < 0.05. CHid: Chidamide; MKK: Mitogen-activated protein kinase kinase.
- Citation: Han H, Guo XY, Wen JX, Zhao XM, Zhou WQ. Immune regulation of Chidamide-induced Linc01010 accumulation in breast cancer cell death. World J Clin Oncol 2025; 16(11): 112514
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/112514.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.112514